search
close_mark

Asya Agres

Asya Agres

26 Jun, 2025

With 14+ years of experience in marketing, Asya has worked in various sectors including creative leadership and consumer brand advertising, and B2B marketing in CRO, CDMO, and clinical technologies/SaaS solutions.

Dr. Kasturi Rao
Read Now

Other Related Articles

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era
Blog Pharmaceutical

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era

01 Apr, 2026

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs
Blog Pharmaceutical

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs

26 Mar, 2026

How to Reduce Notified Body Review Cycles Through Better Clinical Documentation
Blog Medical Devices

How to Reduce Notified Body Review Cycles Through Better Clinical Documentation

18 Mar, 2026

The Great Convergence — Why 2026 is the Year Regulatory “Records” Die
Blog Pharmaceutical

The Great Convergence — Why 2026 is the Year Regulatory “Records” Die

10 Mar, 2026

Raw Material Compliance in Pharmaceuticals: Naming, Pharmacopeial Grade, and Safety Requirements
Blog Pharmaceutical

Raw Material Compliance in Pharmaceuticals: Naming, Pharmacopeial Grade, and Safety Requirements

24 Feb, 2026

EMA Upgrades xEVMPD Web Interface
Blog Pharmaceutical

EMA Upgrades xEVMPD Web Interface

19 Feb, 2026

Raw Material Compliance in Pharmaceuticals
Blog Pharmaceutical

Raw Material Compliance in Pharmaceuticals

13 Feb, 2026

How FDA Reviews Cell & Gene Therapies: A Deep-Dive Regulatory Guide
Blog Pharmaceutical

How FDA Reviews Cell & Gene Therapies: A Deep-Dive Regulatory Guide

06 Feb, 2026

View All